Press Releases

Sep 05, 2023
Twist Bioscience to Present at Upcoming Investor Conferences
Aug 31, 2023
Twist Bioscience Enters into Agreement with Ono Pharmaceutical to Discover Novel Antibodies for Autoimmune Diseases
Aug 22, 2023
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene
Aug 07, 2023
Twist Bioscience to Present at the UBS MedTech, Tools and Genomics Summit 2023
Aug 04, 2023
Twist Bioscience Reports Fiscal Third Quarter 2023 Financial Results
Jul 20, 2023
Twist Bioscience to Report Fiscal 2023 Third Quarter Financial Results on Friday, August 4, 2023
Jul 18, 2023
Twist Bioscience and Cancer Research Horizons Enter into Collaboration to Advance Cancer Research
Jun 26, 2023
Twist Bioscience Publishes Preclinical Data in Diabetes Validating GLP-1R Antagonist Antibody as Potential Treatment for Congenital Hyperinsulinism
Jun 20, 2023
Twist Bioscience Appoints Chet Gandhi as Chief Information Officer
May 31, 2023
Twist Bioscience and CeGaT Launch RNA Fusion Panel to Advance Oncology and Precision Medicine Research